Scarica l'app Stockscreener
7.50
5.18%
-0.41
Dopo l'orario di chiusura:
7.52
0.02
+0.27%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.91
Aprire:
$7.79
Volume 24 ore:
1.57M
Relative Volume:
0.42
Capitalizzazione di mercato:
$312.32M
Reddito:
$123.87M
Utile/perdita netta:
$62.49M
Rapporto P/E:
4.4924
EPS:
1.6695
Flusso di cassa netto:
$-87.53M
1 W Prestazione:
+25.42%
1M Prestazione:
+145.10%
6M Prestazione:
+164.08%
1 anno Prestazione:
+35.87%
Intervallo 1D:
$7.32
$7.98
Intervallo di 1 settimana:
$5.87
$7.99
Portata 52W:
$2.71
$8.70
Agenus Inc Stock (AGEN) Company Profile
Nome
Agenus Inc
Settore
Industria
Telefono
781-674-4410
Indirizzo
3 FORBES ROAD, LEXINGTON, MA
Compare AGEN vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
7.50 | 255.27M | 123.87M | 62.49M | -87.53M | 1.6695 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Iniziato | Robert W. Baird | Outperform |
| 2023-02-28 | Ripresa | H.C. Wainwright | Buy |
| 2022-09-28 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-19 | Ripresa | B. Riley FBR | Buy |
| 2019-04-22 | Iniziato | B. Riley FBR | Buy |
| 2016-10-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Reiterato | Maxim Group | Buy |
| 2016-03-11 | Aggiornamento | Maxim Group | Hold → Buy |
| 2015-12-16 | Iniziato | Jefferies | Buy |
| 2015-10-27 | Downgrade | Maxim Group | Buy → Hold |
| 2015-07-27 | Reiterato | MLV & Co | Buy |
| 2015-06-11 | Iniziato | Oppenheimer | Outperform |
| 2015-01-12 | Reiterato | Maxim Group | Buy |
| 2015-01-09 | Reiterato | MLV & Co | Buy |
| 2015-01-09 | Reiterato | Maxim Group | Buy |
| 2014-12-19 | Reiterato | Maxim Group | Buy |
| 2014-05-08 | Reiterato | Maxim Group | Buy |
| 2014-03-14 | Reiterato | MLV & Co | Buy |
| 2013-10-08 | Reiterato | Maxim Group | Buy |
| 2012-01-05 | Iniziato | William Blair | Outperform |
| 2011-12-01 | Iniziato | Global Hunter Securities | Buy |
Mostra tutto
Agenus Inc Borsa (AGEN) Ultime notizie
AGENUS INC SEC Filing (Jul 28, 2026) - Stock Titan
AGEN|Agenus Inc|Price:6.135|Chg%:+0.155 - TradingKey
BlackRock (AGEN) discloses 2.51M-share, 6% stake in Agenus common stock - Stock Titan
Agenus Inc (AGEN) Balance Sheet - TradingKey
Agenus Inc (AGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agenus Inc (AGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
AGEN|Agenus Inc|Price:5.980|Chg%:-0.210 - TradingKey
Agenus Inc (AGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Agenus Inc (AGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Agenus Inc (AGEN) Cash Flow - TradingKey
Agenus Inc. Revenue Breakdown – NASDAQ:AGEN - TradingView
Agenus Inc. (Nasdaq: AGEN) Q2 2025 Earnings Call | 08/27/2025 Brett Kulak (luI2X2n2sY) - Mshale
AGEN Stock MASSIVE NEWS!? (Thank Me Later Bro) Agenus Stock Best Broker Review Bp (nGoDV3hD3d) - Mshale
Agenus Inc. (AGEN) stock price, news, quote and history - Yahoo Finance UK
Agenus Inc (AGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Agenus Inc - GuruFocus
Agenus Inc. (AGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Do Options Traders Know Something About Agenus Stock We Don't? - Yahoo Finance
Agenus: More Shares, Fresh Starts, And Executive Pay Under The Microscope Sportitalia (bXVgSS8OPp) - Mshale
Agenus Analysis: Strategic Pivot And Financing Valuation Report AGEN $AGEN #AGEN #stockmarket See No Evil Bafta (mAryLCXecM) - Mshale
Agenus Analysis: Strategic Pivot And Financing Valuation Report AGEN $AGEN #AGEN #stockmarket Incendio Montesilvano (bwWkwlpOZa) - Mshale
Agenus Will Present Three Neoajuvant Studies at ESMO26 - Oncodaily
RA Capital and affiliates (NASDAQ: AGEN) disclose 9.99% beneficial ownership in Agenus - Stock Titan
Agenus (AGEN) Registration filing Summary - Quartr
Agenus (NASDAQ: AGEN) registers 2.13M previously issued shares for resale - Stock Titan
Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026 - BioSpace
Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026 - 뉴스와이어
Agenus Inc.AGEN Stock Chart Technical Analysis For 03-09-2020 Giro D'italia (XPKerZ1996) - Mshale
My Take On Agenus's Cash Burn & Legal Risk Keldon Johnson (KIhGnPaajk) - Mshale
Inside the ROBBIN Phase 3 Strategy: Bringing BOT+BAL Into the Neoadjuvant Setting - Oncodaily
Agenus Inc. (AGEN) investors disclose 4.53M-share stake capped at 9.99% - Stock Titan
Agenus Inc. (Nasdaq: AGEN) Q2 2025 Earnings Call | 08/27/2025 Vocm News (LGDv0nXjs0) - Mshale
Agenus abstracts on cancer drug combo accepted at ESMO 2026 - Investing.com
Agenus abstracts on cancer drug combo accepted at ESMO 2026 By Investing.com - Investing.com UK
🔴 Agenus Inc. AGEN Stock Trading Facts 🔴 Gianna Nannini (cYwfB9Crlv) - Mshale
Why Agenus (AGEN Stock) Just Rocketed Up—Buy Now Or Too Late? Grêmio Vs Flamengo (4gW3JuWkOx) - Mshale
A.G.E.N.U.S. 8-K: My Take On The C.F.I.U.S. Delay Ctv News Ottawa (HFy9tZJhiU) - Mshale
Insider Trading AGEN Agenus Inc 2021 05 18 Blowing Dust Advisory (ETsN3n1J0C) - Mshale
Agenus Inc. (Nasdaq: AGEN) Q2 2025 Earnings Call | 08/27/2025 La Casa De Papel (vN5Dv9DbRJ) - Mshale
Agenus (AGEN) Could Be 83% Undervalued On Phase 1b Data And $340 Million Raise - Sahm
Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer - 뉴스와이어
Agenus Surges 83% On $340 Million Financing: The Road To A 2030 Breakthrough (NASDAQ:AGEN) - Seeking Alpha
Agenus stock doubles as biotech narrows Phase 3 bet - AOL.com
Form 4 Agenus Inc For: 14 July By Investing.com - Investing.com Nigeria
Agenus Inc. (NASDAQ: AGEN) director takes 4,852-share stock salary grant - Stock Titan
AGEN Stock Pulls Back After Huge Spike As Traders Dig Into Financials - StocksToTrade
Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN Trial in MSS Colon Cancer - Oncodaily
Jennifer S. Buell: Agenus’ Next Chapter in Early Immuno-Oncology With Phase 3 ROBBIN Trial - Oncodaily
From “Most Promising” to Phase 3: Up to $340M to Advance BOT/BAL in MSS Colon Cancer - Oncodaily
AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot - The Globe and Mail
Why Is Agenus Stock Falling on Tuesday? - Benzinga
Agenus Inc Azioni (AGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):